Onderneming Boji Medical Technology Co.,Ltd.
Aandelen
300404
CNE100001Y00
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
8,07 CNY | +0,88% | +4,40% | -9,83% |
Vakgebied
Aantal werknemers: 1 186
Verkoop per activiteit
CNY in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Clinical Research Services
74,6
%
| 277 | 65,4 % | 415 | 74,6 % | +49,58% |
Pre-clinical Research Services
14,1
%
| 74 | 17,4 % | 78 | 14,1 % | +6,19% |
Other Consultancy Services
8,7
%
| 41 | 9,6 % | 49 | 8,7 % | +19,06% |
Other Business
2,6
%
| 13 | 3,0 % | 14 | 2,6 % | +12,81% |
Pre-clinical Independent Research and Development
0,0
%
| 11 | 2,7 % | 0 | 0,0 % | -97,78% |
Verkoop per regio
CNY in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
China
99,4
%
| 408 | 99,3 % | 553 | 99,4 % | +35,42% |
Hong Kong, Macau and Taiwan
0,3
%
| 2 | 0,5 % | 2 | 0,3 % | -7,02% |
Abroad
0,2
%
| 1 | 0,2 % | 1 | 0,2 % | +35,03% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ting Cun Wang
CEO | Chief Executive Officer | 59 | 11-06-11 |
Xiu Qing Ou
DFI | Director of Finance/CFO | 42 | 01-12-03 |
Bo Tan
BRD | Director/Board Member | 42 | 01-10-05 |
Quan Zhu
BRD | Director/Board Member | 52 | 01-02-08 |
Shao Hua Chen
IRC | Investor Relations Contact | - | - |
Fang Qun Wei
SEC | Corporate Secretary | 39 | 01-06-11 |
Yu Ping Han
PRN | Corporate Officer/Principal | 51 | 01-11-08 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Ting Cun Wang
CEO | Chief Executive Officer | 59 | 11-06-11 |
Yu Ping Han
PRN | Corporate Officer/Principal | 51 | 01-11-08 |
Quan Zhu
BRD | Director/Board Member | 52 | 01-02-08 |
Bo Tan
BRD | Director/Board Member | 42 | 01-10-05 |
Ke Jian Zhang
BRD | Director/Board Member | 68 | 28-07-20 |
Kang Xie
BRD | Director/Board Member | 61 | 17-05-22 |
Qing Chen
BRD | Director/Board Member | 70 | 28-07-20 |
Jing Chun Liu
CHM | Chairman | - | 03-08-23 |
Fang Wang
BRD | Director/Board Member | 38 | 28-07-20 |
Peidan Xian
BRD | Director/Board Member | - | 02-08-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 382 005 238 | 225 315 063 ( 58,98 %) | 800 000 ( 0,2094 %) | 58,98 % |
Bedrijfsgegevens
Boji Medical Technology Co., Ltd.
7/F, Block A, Vanke Cloud Plaza 1933 Huaguan Road
510640, Guangzhou
+
http://www.gzboji.comSector
Verkoop per activiteit
Verkoop per regio
Herzieningen van WPA
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-9,83% | 421 mln. | |
+21,74% | 46,81 mld. | |
-0,97% | 41,37 mld. | |
+47,07% | 41,29 mld. | |
-3,52% | 28,87 mld. | |
+11,12% | 26,06 mld. | |
-19,37% | 19,13 mld. | |
+31,18% | 12,39 mld. | |
-0,04% | 12,08 mld. | |
+0,39% | 11,96 mld. |
- Beurs
- Aandelen
- Koers 300404
- Onderneming Boji Medical Technology Co.,Ltd.